Nucleolar Positivity for CD20

By  

Acta Cytologica, Vol. 49, Iss. 4, 2011-02 ,pp. : 365-372

Karger

Access to resources Recommend Favorite

Therapeutic potential of CD4 + CD25 + regulatory T cells in allogeneic transplantation

By Cohen JL   Salomon BL  

Cytotherapy, Vol. 7, Iss. 2, 2005-05 ,pp. : 166-170

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Engineered CD20-specific primary human cytotoxic T lymphocytes for targeting B-cell malignancy

By Jensen Mc   Cooper Ljn   Wu Am   Forman Sj   Raubitschek A  

Cytotherapy, Vol. 5, Iss. 2, 2003-01 ,pp. : 131-138

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Autologous transplantation of CD133 + BM-derived stem cells as a therapeutic option for dilatative cardiomyopathy

By Ghodsizad A   Ruhparwar A   Marktanner R   Borowski A   Mohammad Hasani Mr   Poll L   Vshivkov I   Stoldt V   Voelkel T   Piechaczek C   Burchardt Er   Stockschlaeder M   Sucker C   Gams E   Klein Hm  

Cytotherapy, Vol. 8, Iss. 3, 2006-05 ,pp. : 308-310

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Peripheral endothelial progenitor cells (CD133+) for therapeutic vasculogenesis in a patient with critical limb ischemia. One year follow-up

By Cañizo MC   Lozano F.   González-Porras JR   Barros M.   López-Holgado N.   Briz E.   Sánchez-Guijo FM  

Cytotherapy, Vol. 9, Iss. 1, 2007-01 ,pp. : 99-102

Ashgate Publishing Ltd

Access to resources Recommend Favorite